Gruentzig's position
Gruentzig wanted the procedure to be safe and useful. He recognized that many problems were yet to be solved and he carefully explored their solution. He was conservative in his statements about the value of the technique but was aggressive in his research efforts to solve the problems associated with it. He did not believe the procedure should be used as a substitute for bypass surgery in all patients. Rather, he preferred to perform the procedure in patients with angina who had single-vessel coronary artery disease for four reasons. First, he often stated something like, "It's a shame to have a big operation when there is only one small, discrete obstruction in one coronary artery." He believed, too, that there were well-defined indications for bypass surgery in patients with discrete multivessel coronary disease. Second, he realized that the most serious drawback to coronary angioplasty was the high rate of restenosis (25% to 30% in 6 months). He Death occurred in 0.6% of the patients. Myocardial infarction occurred in 1.2%, and emergency coronary bypass surgery was used in 3.6% of the patients. Al-though he had previously called for a randomized trial in which coronary angioplasty would be compared with bypass surgery in patients with angina and multivessel coronary disease, he and his colleagues believed they had sufficient evidence to apply for an NIH grant to implement such a study. Not only has the grant initiated by Gruentzig and his colleagues recently been approved, but the NHLBI has also mounted a multicenter trial, the Bypass Angioplasty Revascularization Investigation (BARI), to examine the question more broadly.
Development of a new procedure
Many new procedures pass through four stages on their way to being accepted or rejected by physicians and patients.
Stage one is initiated because a creative person has an idea that he or she believes would be useful in the diagnosis or treatment of a patient with a certain disease. Gruentzig had the idea many years before he accomplished the feat.
Stage two begins when the individual begins to apply the procedure. Usually the procedure is used in the animal laboratory before it is used in humans. He or she may have the instruments available to implement the new procedure or it may be necessary to develop the tools to accomplish the objective. The tools available in the beginning were inadequate for Gruentzig's needs so he set about developing the balloon catheter and a pressure device required to perform the task. This was tedious work but he persisted until it was accomplished. 3 Stage three begins when the creative individual realizes that the crude tools used in the beginning are not satisfactory for lieve troublesome symptoms for a significant period of time? (This question implies that the degree of relief produced must be compared with other methods used to relieve symptoms.) Does the procedure prevent serious events from occurring during a significant period of time? (The answer to this requires an estimate of the complications resulting from the procedure and implies that the number of events after angioplasty must be compared with the number of events occurring after other methods of therapy.) Does the procedure create a feeling of security in the minds of patients and their physicians? (This question implies that the feeling of security must be compared with the security associated with other procedures.) It is now time to engage in additional and critical research that will permit us to answer these questions.
The current "state of the art" Most of the development, thus far, has been almost exclusively limited to the gradual improvement in the technology and skill. There are defensible indications and contraindications but more research is indicated before the technique can be applied, or not applied, to other subsets of coronary disease.
(1) Coronary angioplasty should not be used in patients with left main coronary artery obstruction unless some protection is offered by patent bypass grafts from a previous bypass operation to the anterior descending or circumflex artery. The one exception to this rule is when myocardial ischemia, electrical-mechanical dissociation, and hypotension occur as a complication of coronary arteriography in a patient with left main coronary artery obstruction.
(2) Coronary angioplasty may be used in patients with angina pectoris caused by discrete obstruction of a single coronary artery. One can expect the procedure to relieve angina in most of the patients and that the procedure can be done safely.
(3) Coronary angioplasty may be used to relieve the stenosis in a saphenous vein bypass graft. The effort is more successful when the stenosis site is at a distal anastomatic location. More research is needed to determine the long-range value of the procedure.
(4) Coronary angioplasty may be used to dilate the stenosed artery that is responsible for myocardial infarction. Arterial patency must be achieved during the first few hours after pain caused by myocardial ischemia begins and may be used with or without thrombolytic therapy. More research is needed, however, to determine the exact role of the procedure when it is used in this situation because it may or may not be the definitive procedure for this clinical problem. (5) Restenosis occurs in 25% to 30% of the patients within 6 months. The figure may be much higher in certain subsets of patients such as patients who have angioplasty for total occlusion of an artery. Accordingly, a major research effort must be directed toward the restenosis problem, which looms as the greatest drawback to an expanded application of the procedure.
(6) The value of the procedure, when it is used in patients with multivessel disease, cannot be determined without a randomized trial. Patients with class I and II angina pectoris who undergo angioplasty should be randomized against medical therapy when the clinical markers, coronary anatomy, and ejection fractions, are similar to those reported in the 1983 Coronary Artery Surgery Study4 (a compilation in which almost all of the patients were at low risk); patients with angina should be randomized against bypass surgery when the clinical markers, coronary anatomy, and ejection fractions are similar to those reported in the Veterans Administration study of 19735 and 19846 and the European study reported in 1983.7 (7) Statements by some, and the behavior of others, suggest that they believe coronary angioplasty is a substitute for surgery in patients with multivessel disease. It may or may not be. The procedure has not been compared with bypass surgery and, until the proper research has been done, it is wise to be cautious in one's statements about the subject.
(8) The procedure is sometimes used in symptomatic patients with triple-vessel coronary obstruction when the doctor performing the angioplasty dilates a single vessel that is thought to cause the symptoms. Perhaps it is possible to do this in a reliable fashion, but that does not signify that the patient might not live longer if all vessels were bypassed.
(9) Some individuals dilate 10 or more obstructions at a single catheterization. This is a great technical feat but it is not the same as being able to defend that such an approach is superior to other methods of treatment. I would be concerned if less than critical stenoses are dilated. Should such be the case, and if restenosis occurs at the site of dilatation, it is conceivable that the procedure could do harm in such a patient.
(10) Some individuals who perform angioplasty believe it is proper to dilate a coronary artery or arteries every few months for many years. There may be instances when this approach is superior to coronary bypass surgery but such instances must be rare.
(11) Some say that patients do not want bypass surgery so they accept angioplasty. Of course, they don't want surgery. Neither do they want coronary angioplasty. The fact is, they don't want to have coronary disease at all. I have learned, howtvicr, that pattcistl want a procedure that relieves sylptoiris. pciiriits them to live longer, prevenits c iits ca-btd b-the disease, and gives them and their physiciani a scinse of security. We hope the recently tunded ratildoililzed study comparing the value ot coroinary ar}grplaoty with coronary bypass surgery in patienits with ioaltivessel disease will clarify which thei4apy iS .ikst beneficial for subsets of patient with thisb pobkein However, until we have the results ot the riaiiuiii-lcd trial, we must offer the procedure that is likely, tu be the most beneficial to the patient. Our opirnion abunt an individual patient should be suppoited by ss.-lciitific data that have been carefully sciutiniLed by the physicians working in the field. It has been n-my experience that very few patients will not accept surgery it the physician believes it is best for theim in termis ot the four objectives just mentioned.
Conclusions
The technique of coronary angioplasty has been refined and, when applied by skilled workers in properly selected patients, is associated with an excellent initial result, low mortality, and an acceptable comiplication rate. Clearly, the procedure can be used to relieve angina in patients with single-vessel disease.
The high restenosis rate of 25% to 30% within 6 months must be lowered for the piocedure to gaill total acceptance. Our group and others are addressing this problem.
My plea is a simple one. Let us not Contuse the progress made in refining the technique with the value obtained by its use. So far, most of the work has been directed to improving the technique and relieving angina. In fact, most of the work has been related to the first three stages of the four stages a new pioWedui-e goes through on its way to acceptance or rejectioni. A he value beyond the third stage of developiment must be determined by comparing angigoplasty with othei iiiethods of treatment. Accordingly, within a few weekb we will begin the recently funded randoimlzed study to determine the value of anigioplasty in pdtients with multivessel coronary obstruction.
Gruentzig's view should be heeded. He was conservative in his statements about the value of the p-ocedure but was aggressive in his iesearch eftorts to solve the probleins. Let us all hope that this pruiiisinig p10e--dure is not inappropriately applied before the iescaich has been completed that mnay justity its expanded use
